mTOR signaling: PLD takes center stage
暂无分享,去创建一个
Jie Chen | Yuting Sun | Jie Chen | Yuting Sun
[1] G. Du,et al. Ca2+‐ and phospholipase D‐dependent and ‐independent pathways activate mTOR signaling , 2003, FEBS letters.
[2] In-Hyun Park,et al. PLD1 Regulates mTOR Signaling and Mediates Cdc42 Activation of S6K1 , 2003, Current Biology.
[3] A. Gingras,et al. Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.
[4] C. Proud,et al. PRAS40 Is a Target for Mammalian Target of Rapamycin Complex 1 and Is Required for Signaling Downstream of This Complex* , 2007, Journal of Biological Chemistry.
[5] A. Nakashima,et al. The Proline-rich Akt Substrate of 40 kDa (PRAS40) Is a Physiological Substrate of Mammalian Target of Rapamycin Complex 1* , 2007, Journal of Biological Chemistry.
[6] David A Foster,et al. Alternative phospholipase D/mTOR survival signal in human breast cancer cells , 2005, Oncogene.
[7] David M. Sabatini,et al. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.
[8] L. Cantley,et al. Phosphoinositide kinases. , 1998, Annual review of biochemistry.
[9] Takehiko Sasaki,et al. Essential Role for Phospholipase D2 Activation Downstream of ERK MAP Kinase in Nerve Growth Factor-stimulated Neurite Outgrowth from PC12 Cells* , 2004, Journal of Biological Chemistry.
[10] H. Janssens,et al. BMC Developmental Biology BioMed Central , 2006 .
[11] X. Bai,et al. Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38 , 2007, Science.
[12] M. Lemmon,et al. Phosphoinositide Recognition Domains , 2003, Traffic.
[13] James T. Murray,et al. hVps34 Is a Nutrient-regulated Lipid Kinase Required for Activation of p70 S6 Kinase* , 2005, Journal of Biological Chemistry.
[14] Xinsheng Gao,et al. Tuberous sclerosis complex: from Drosophila to human disease. , 2004, Trends in cell biology.
[15] J. Bos,et al. Regulation of the small GTPase Rheb by amino acids , 2006, Oncogene.
[16] Ping Huang,et al. Insulin-stimulated plasma membrane fusion of Glut4 glucose transporter-containing vesicles is regulated by phospholipase D1. , 2005, Molecular biology of the cell.
[17] S. Chien,et al. The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[18] W. Stark,et al. Regulation of phototransduction responsiveness and retinal degeneration by a phospholipase D–generated signaling lipid , 2005, The Journal of cell biology.
[19] A. Gingras,et al. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. , 1999, Annual review of biochemistry.
[20] G. Laurent,et al. Syk-dependent mTOR activation in follicular lymphoma cells. , 2006, Blood.
[21] J. Blenis,et al. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.
[22] R. Roth,et al. PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding* , 2007, Journal of Biological Chemistry.
[23] J. Blenis,et al. The 70 kDa S6 Kinase Complexes with and Is Activated by the Rho Family G Proteins Cdc42 and Rac1 , 1996, Cell.
[24] J. Exton. Regulation of phospholipase D , 2002, Biochimica et biophysica acta.
[25] N. Sonenberg,et al. Upstream and downstream of mTOR. , 2004, Genes & development.
[26] Y. Akao,et al. Involvement of phospholipase D1 in collagen type I production of human dermal fibroblasts. , 2006, Biochemical and biophysical research communications.
[27] K. Meier,et al. Expression of phospholipase D isoforms in mammalian cells. , 1999, Biochimica et biophysica acta.
[28] G. Hortobagyi,et al. IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway , 2007, Cell.
[29] M. Hall,et al. TOR Signaling in Growth and Metabolism , 2006, Cell.
[30] P. Worley,et al. Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells , 2002, Oncogene.
[31] F. Natt,et al. Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34. , 2008, Cell metabolism.
[32] M. Shi,et al. Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras. , 2007, Cancer letters.
[33] G. Prestwich,et al. Activation of mTOR signaling by novel fluoromethylene phosphonate analogues of phosphatidic acid. , 2004, Bioorganic & medicinal chemistry letters.
[34] J. Avruch,et al. Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency* , 2005, Journal of Biological Chemistry.
[35] S. Sethu,et al. Phospholipase D1 plays a key role in TNF-alpha signaling. , 2008, Journal of immunology.
[36] K. Inoki,et al. TSC2: filling the GAP in the mTOR signaling pathway. , 2004, Trends in biochemical sciences.
[37] Ming You,et al. TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth , 2006, Cell.
[38] M. Frohman,et al. Phospholipase D structure and regulation. , 1999, Chemistry and physics of lipids.
[39] S. Nicosia,et al. Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin* , 2002, The Journal of Biological Chemistry.
[40] D. A. Foster,et al. Regulation of mTOR by phosphatidic acid? , 2007, Cancer Research.
[41] K. Inoki,et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.
[42] J. Blenis,et al. TOS Motif-Mediated Raptor Binding Regulates 4E-BP1 Multisite Phosphorylation and Function , 2003, Current Biology.
[43] D. A. Foster,et al. Phospholipase D confers rapamycin resistance in human breast cancer cells , 2003, Oncogene.
[44] Y. Kam,et al. Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[45] David M Sabatini,et al. Defining the role of mTOR in cancer. , 2007, Cancer cell.
[46] S. Rudge,et al. Regulation and function of PLDs in yeast. , 1999, Biochimica et biophysica acta.
[47] T. P. Neufeld,et al. Regulation of TORC1 by Rag GTPases in nutrient response , 2008, Nature Cell Biology.
[48] L. Cantley,et al. Rheb fills a GAP between TSC and TOR. , 2003, Trends in biochemical sciences.
[49] T. P. Neufeld,et al. The class III PI(3)K Vps34 promotes autophagy and endocytosis but not TOR signaling in Drosophila , 2008, The Journal of cell biology.
[50] K. Jakobs,et al. Phospholipase D Stimulation by Receptor Tyrosine Kinases Mediated by Protein Kinase C and a Ras/Ral Signaling Cascade* , 1999, The Journal of Biological Chemistry.
[51] J. Zempleni,et al. Amino acid-sensing mTOR signaling. , 2005 .
[52] Y. Kam,et al. Phospholipase D Activity Is Required for Actin Stress Fiber Formation in Fibroblasts , 2001, Molecular and Cellular Biology.
[53] M. Hall,et al. The expanding TOR signaling network. , 2005, Current opinion in cell biology.
[54] V. Holla,et al. Requirement of phospholipase D1 activity in H-RasV12-induced transformation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[55] I. Mérida,et al. Modulation of the Mammalian Target of Rapamycin Pathway by Diacylglycerol Kinase-produced Phosphatidic Acid* , 2005, Journal of Biological Chemistry.
[56] D. Kwiatkowski,et al. Molecular genetic advances in tuberous sclerosis , 2000, Human Genetics.
[57] D. Alessi,et al. TSC1–TSC2: a complex tale of PKB-mediated S6K regulation , 2002, Nature Cell Biology.
[58] Scott M. Hammond,et al. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization , 1997, Current Biology.
[59] M. Carr,et al. Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR , 2008, Oncogene.
[60] Paul Tempst,et al. Phosphorylation and Functional Inactivation of TSC2 by Erk Implications for Tuberous Sclerosisand Cancer Pathogenesis , 2005, Cell.
[61] Mee-Sup Yoon,et al. PLD regulates myoblast differentiation through the mTOR-IGF2 pathway , 2008, Journal of Cell Science.
[62] J. Avruch,et al. The Mammalian Target of Rapamycin (mTOR) Partner, Raptor, Binds the mTOR Substrates p70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) Motif* , 2003, The Journal of Biological Chemistry.
[63] Y. Akao,et al. Negative regulation of melanogenesis by phospholipase D1 through mTOR/p70 S6 kinase 1 signaling in mouse B16 melanoma cells , 2005, Journal of cellular physiology.
[64] Jussi Taipale,et al. Identification of pathways regulating cell size and cell-cycle progression by RNAi , 2006, Nature.
[65] S. Jang,et al. PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals. , 2006, Cellular signalling.
[66] D. Bar-Sagi,et al. Honokiol Suppresses Survival Signals Mediated by Ras-Dependent Phospholipase D Activity in Human Cancer Cells , 2008, Clinical Cancer Research.
[67] Ping Huang,et al. Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. , 2003, Molecular biology of the cell.
[68] J. Lawrence,et al. Two Motifs in the Translational Repressor PHAS-I Required for Efficient Phosphorylation by Mammalian Target of Rapamycin and for Recognition by Raptor* , 2003, Journal of Biological Chemistry.
[69] L. Mcphail,et al. Phospholipase D2‐derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[70] Steven P Gygi,et al. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[71] P. Pandolfi,et al. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. , 2007, Cancer research.
[72] A. Ball,et al. Inhibition of lysophosphatidic acid acyltransferase beta disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells. , 2003, Molecular cancer therapeutics.
[73] G. Fiucci,et al. Phospholipase D: molecular and cell biology of a novel gene family. , 2000, The Biochemical journal.
[74] S. Carr,et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. , 2007, Molecular cell.
[75] Z. Freyberg,et al. Intracellular localization of phospholipase D1 in mammalian cells. , 2001, Molecular biology of the cell.
[76] David J. Kwiatkowski,et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[77] Jie Chen,et al. A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling. , 2002, Biochemical pharmacology.
[78] Tian Xu,et al. Akt regulates growth by directly phosphorylating Tsc2 , 2002, Nature Cell Biology.
[79] H. A. Brown,et al. Phospholipase D1 is an effector of Rheb in the mTOR pathway , 2008, Proceedings of the National Academy of Sciences.
[80] J. Hwang,et al. Activation of phospholipase D by 8‐Br‐cAMP occurs through novel pathway involving Src, Ras, and ERK in human endometrial stromal cells , 2005, FEBS letters.
[81] Jie Chen,et al. Phosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling , 2001, Science.
[82] J. Avruch,et al. The Rheb Switch 2 Segment Is Critical for Signaling to Target of Rapamycin Complex 1* , 2007, Journal of Biological Chemistry.
[83] F. Natt,et al. Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[84] Steven J. Marygold,et al. Growth Signaling: TSC Takes Its Place , 2002, Current Biology.
[85] Timothy J. Griffin,et al. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 , 2007, Nature Cell Biology.
[86] Joseph Avruch,et al. Rheb Binds and Regulates the mTOR Kinase , 2005, Current Biology.
[87] M. Shi,et al. Phospholipase D Couples Survival and Migration Signals in Stress Response of Human Cancer Cells* , 2006, Journal of Biological Chemistry.
[88] C. Proud,et al. The Tuberous Sclerosis Protein TSC2 Is Not Required for the Regulation of the Mammalian Target of Rapamycin by Amino Acids and Certain Cellular Stresses* , 2005, Journal of Biological Chemistry.
[89] G. Du,et al. Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase C gamma and protein kinase C alpha signalling cascade. , 2000, The Biochemical journal.
[90] J. B. Park,et al. Activation of astroglial phospholipase D activity by phorbol ester involves ARF and Rho proteins. , 2000, Biochimica et biophysica acta.
[91] D. A. Foster,et al. Phospholipase D in cell proliferation and cancer. , 2003, Molecular cancer research : MCR.
[92] D. Sabatini,et al. Growing roles for the mTOR pathway. , 2005, Current opinion in cell biology.
[93] G. Laurie,et al. Restricted epithelial proliferation by lacritin via PKCα-dependent NFAT and mTOR pathways , 2006, The Journal of cell biology.
[94] M. Frohman,et al. Mammalian phospholipase D structure and regulation. , 1999, Biochimica et biophysica acta.